| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Achieving lipid targets in adults with type 2 diabetes: The Stop Atherosclerosis in Native Diabetics Study
|
Russell, Marie
|
|
2010
|
4 |
5 |
p. 435-443
9 p.
|
artikel
|
| 2 |
Activation of intracellular signaling systems by high-density lipoproteins
|
Toth, Peter P.
|
|
2010
|
4 |
5 |
p. 376-381
6 p.
|
artikel
|
| 3 |
Assessing and addressing risk of cardiovascular disease in perimenopausal and early postmenopausal women †
|
Brown, W. Virgil
|
|
2010
|
4 |
5 |
p. 324-334
11 p.
|
artikel
|
| 4 |
Asymptomatic 5-year-old child with hypothyroidism and concurrent severe hypercholesterolemia
|
Harbison, Anna Lonyai
|
|
2010
|
4 |
5 |
p. 444-445
2 p.
|
artikel
|
| 5 |
Complete Apo AI Deficiency in an Iraqi Mandaean Family: Case studies and review of the literature
|
Al-Sarraf, Ahmad
|
|
2010
|
4 |
5 |
p. 420-426
7 p.
|
artikel
|
| 6 |
Defining the challenges of familial hypercholesterolemia screening: Introduction
|
Hopkins, Paul N.
|
|
2010
|
4 |
5 |
p. 342-345
4 p.
|
artikel
|
| 7 |
Defining the challenges of FH Screening for familial hypercholesterolemia
|
Defesche, Joep C.
|
|
2010
|
4 |
5 |
p. 338-341
4 p.
|
artikel
|
| 8 |
Diet-supported aerobic exercise reduces blood endothelin-1 and nitric oxide levels in individuals with impaired glucose tolerance
|
Kasımay, Özgür
|
|
2010
|
4 |
5 |
p. 427-434
8 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2010
|
4 |
5 |
p. i-ii
nvt p.
|
artikel
|
| 10 |
Emerging high-density lipoprotein infusion therapies: Fulfilling the promise of epidemiology?
|
Tardif, Jean-Claude
|
|
2010
|
4 |
5 |
p. 399-404
6 p.
|
artikel
|
| 11 |
Familial hypercholesterolemia: Current treatment options and patient selection for low-density lipoprotein apheresis
|
Hemphill, Linda C.
|
|
2010
|
4 |
5 |
p. 346-349
4 p.
|
artikel
|
| 12 |
From the Editor-in-Chief
|
Brown, W. Virgil
|
|
2010
|
4 |
5 |
p. 321-322
2 p.
|
artikel
|
| 13 |
Functions of cholesterol ester transfer protein and relationship to coronary artery disease risk
|
Tall, Alan R.
|
|
2010
|
4 |
5 |
p. 389-393
5 p.
|
artikel
|
| 14 |
High-density lipoprotein particles, coronary heart disease, and niacin
|
Asztalos, Bela F.
|
|
2010
|
4 |
5 |
p. 405-410
6 p.
|
artikel
|
| 15 |
High-density lipoproteins: Marker of cardiovascular risk and therapeutic target
|
Toth, Peter P.
|
|
2010
|
4 |
5 |
p. 359-364
6 p.
|
artikel
|
| 16 |
High-density lipoprotein therapeutics and cardiovascular prevention
|
Fazio, Sergio
|
|
2010
|
4 |
5 |
p. 411-419
9 p.
|
artikel
|
| 17 |
Insights from recent meta-analysis: Role of high-density lipoprotein cholesterol in reducing cardiovascular events and rates of atherosclerotic disease progression
|
Negi, Smita
|
|
2010
|
4 |
5 |
p. 365-370
6 p.
|
artikel
|
| 18 |
Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein
|
Smith, Jonathan D.
|
|
2010
|
4 |
5 |
p. 382-388
7 p.
|
artikel
|
| 19 |
News from the NLA
|
|
|
2010
|
4 |
5 |
p. 323-
1 p.
|
artikel
|
| 20 |
NLA Symposium screening and treatment of familial hypercholesterolemia: How can we do better? Opening and introductions
|
McGowan, Mary
|
|
2010
|
4 |
5 |
p. 335-337
3 p.
|
artikel
|
| 21 |
Novel therapies and new targets of treatment for familial hypercholesterolemia
|
Goldberg, Anne Carol
|
|
2010
|
4 |
5 |
p. 350-356
7 p.
|
artikel
|
| 22 |
Question-and-answer session
|
McGowan, Mary
|
|
2010
|
4 |
5 |
p. 357-358
2 p.
|
artikel
|
| 23 |
Table of Contents
|
|
|
2010
|
4 |
5 |
p. iii-iv
nvt p.
|
artikel
|
| 24 |
The protein cargo of HDL: Implications for vascular wall biology and therapeutics
|
Heinecke, Jay W.
|
|
2010
|
4 |
5 |
p. 371-375
5 p.
|
artikel
|
| 25 |
Update on CETP inhibition
|
Davidson, Michael H.
|
|
2010
|
4 |
5 |
p. 394-398
5 p.
|
artikel
|
Tijdschrift beschrijving